John Wrangle to Antibodies, Monoclonal, Humanized
This is a "connection" page, showing publications John Wrangle has written about Antibodies, Monoclonal, Humanized.
Connection Strength
0.078
-
A Phase 1-2 Study of Rovalpituzumab Tesirine in Combination With Nivolumab Plus or Minus Ipilimumab in Patients With Previously Treated Extensive-Stage SCLC. J Thorac Oncol. 2021 09; 16(9):1559-1569.
Score: 0.043
-
The clinical implications of immunogenomics in colorectal cancer: A path for precision medicine. Cancer. 2018 04 15; 124(8):1650-1659.
Score: 0.035